Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era



Rating:

Share or cite this content

Citations should be made in the following way:
C. Prat Aymerich (Badalona (Barcelona), Spain). Advances in diagnostic tools for lower respiratory tract infections. Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era

Member's Comments

No comment yet.

Related content which might interest you: Impact of appropriate diagnostics on the management of respiratory tract infections Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Linking pathophysiology of lower respiratory tract infections with clinical expression Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007 Role of α- and β-defensins in lower respiratory tract infections Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections Year: 2007 Guidelines for the management of adult lower respiratory tract infections Source: Guideline 2005 Year: 2005 Guidelines for the management of adult lower respiratory tract infections Source: Eur Respir J 2005; 26: 1138-1180 Year: 2005 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 New guidelines for the management of adult lower respiratory tract infections Source: Eur Respir J 2011; 38: 1250-1251 Year: 2011 Guidelines for management of adult community-acquired lower respiratory tract infections Source: Guideline 1998 Year: 1998 Lower respiratory tract infections: diagnosis and treatment in clinical practice Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014 Contribution of serological tests to the diagnosis of lower respiratory tract infections(LRTI) Source: Eur Respir J 2004; 24: Suppl. 48, 373s Year: 2004 Clinical scoring systems for lower respiratory tract infections Source: Annual Congress 2011 - ERS/ESCMID Guidelines: Management of lower respiratory tract infections: scores, biomarkers and beyond Year: 2011 Use of diagnostic tests in respiratory tract infections: an economic analysis. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Viral agents in children with lower respiratory tract infection Source: Eur Respir J 2006; 28: Suppl. 50, 487s Year: 2006 The management of severe sepsis in respiratory tract infections Source: Annual Congress 2013 –ME14 The management of severe sepsis in respiratory tract infections Year: 2013 Seasonal variation of viral lower respiratory tract infections in immunocompromised patients undergoing diagnostic bronchoscopy Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Lower respiratory tract infections: challenges in children and adults Source: Virtual Congress 2020 – Respiratory diseases in children and adults Year: 2020 Biomarkers in lower respiratory tract infections Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 Fatal outcome in lower respiratory tract infections Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004